Form 4: Teladoc Health Executive Acquires 37,900 Restricted Stock Units

Nikolaos P. Nanis, Chief Technology Officer of Teladoc Health, acquired 37,900 restricted stock units on March 19, 2024, according to a recent SEC filing.

Summary

• An SEC Form 4 filing reveals that Nikolaos P. Nanis, the Chief Technology Officer of Teladoc Health, Inc. (TDOC), acquired 37,900 restricted stock units on March 19, 2024.
• These restricted stock units represent a contingent right to receive one share of TDOC common stock each.
• The vesting schedule for these units is as follows: one-third vests on the first anniversary of the grant date, and the remaining units vest in eight substantially equal quarterly installments starting on June 1, 2025.
• Following this transaction, Mr. Nanis directly owns 37,900 derivative securities.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently indicate positive or negative sentiment, but rather reports a transaction.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency into the holdings of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder confidence due to the executive increasing their stake in the company.

Key Dates